How Fed Policy, Portfolio Lending Dynamics, and the 'Doctor Tax' Shape Your Borrowing Costs

TL;DR — Key Takeaways
- Physician loan rates will likely remain in the 6.25%-7.0% range throughout 2026, with only modest declines possible by year-end.
- Mortgage rates don't automatically drop when the Fed cuts rates—they track 10-year Treasury yields and mortgage-backed securities markets instead.
- Physician loans carry a 0.125%-0.50% rate premium (the 'doctor tax') above conventional mortgages, adding roughly $25,000-$30,000 in extra interest on a $500,000 loan over 30 years (depending on the underlying rate).
- Shopping across 3-5 lenders can reveal rate differences of 0.25%-0.50%—thousands in annual savings.
- Waiting for lower rates risks home price appreciation that negates any rate savings—buying now and building equity often outperforms timing the market.
- ARMs taken during pandemic years (2.5%-3.5% rates) are now adjusting to 5%+ rates, creating significant payment shocks for many physician borrowers.
- Locum/1099 physicians face rate penalties of 0.5%-1.0% above standard physician loan rates or outright exclusion from programs.
The relationship between Federal Reserve policy and the mortgage rates physicians actually pay is far more complex than most doctors realize. As we move into 2026, understanding this complexity has become essential for making informed borrowing decisions.
In nearly twenty years of working with physicians and their families, I've seen the same pattern over and over: smart doctors assuming that when the Fed cuts rates, their mortgage should automatically get cheaper. I wish it were that simple. When my wife was finishing training, we had to sort through the same questions—Should we wait for better rates? Are physician loans really worth the premium? That's the perspective I'm writing from here.
In this guide, we’ll look at how physician mortgage interest rates in 2026 are likely to behave, what’s behind the numbers, and how to make a calm, practical decision.
Why Mortgage Rates Don't Automatically Fall When the Fed Cuts
When the Federal Reserve lowers its benchmark interest rate, the natural expectation is that mortgage rates will follow. In practice, this connection is indirect and filtered through multiple layers of financial markets. The federal funds rate directly influences short-term borrowing costs like credit cards and home equity lines of credit, but mortgage rates operate on a different trajectory entirely.
When I sit down with residents or early attendings, one of the first things I explain is this: your mortgage rate cares a lot more about the 10-year Treasury and mortgage-backed securities than it does about the Fed's headline number on the news.
The spread between 10-year Treasury yields and mortgage rates has widened to approximately 2.5 percentage points in the post-pandemic era (according to industry analysis from MBS Highway and mortgage banking data)—significantly higher than historical norms of 1.5-1.8 percentage points. This expanded spread is why homebuyers face higher mortgage costs than Treasury movements alone would predict.
Long-term mortgage rates, particularly the 30-year fixed products most physicians choose, track the yield on 10-year U.S. Treasury bonds rather than the Fed's overnight lending rate. This Treasury yield reflects investor sentiment about the economy's direction, inflation risk, and global stability. When investors anticipate higher inflation or economic uncertainty, they demand higher yields on Treasury bonds, which in turn drives mortgage rates upward—even if the Fed is actively cutting rates.
The mechanics become more complex when considering mortgage-backed securities. Most U.S. mortgages are bundled into securities by Fannie Mae and Freddie Mac and sold to global investors. The supply and demand dynamics of these mortgage-backed securities create an additional layer of pricing that operates independently of Fed policy. If the Fed reduces its purchases of these securities, or if global investors view them as riskier assets, mortgage rates can rise despite falling benchmark rates.
Following the Fed rate cuts in 2025, 30-year mortgage rates declined modestly to a range of 6.26% to 6.58%—the lowest levels in nearly a year but still substantially higher than the pandemic-era lows below 3% in 2021. More importantly, the spread between 10-year Treasury yields and mortgage rates has widened to approximately 2.5 percentage points in the post-pandemic era, significantly higher than historical norms. This expanded spread means homebuyers face higher mortgage costs than Treasury movements alone would predict.
Inflation expectations remain the dominant force shaping this landscape. Market participants price mortgage-backed securities based on future inflation scenarios, prepayment risk, and economic volatility. Until these fundamental concerns shift materially, mortgage rates will remain elevated regardless of Fed policy signals.
In plain English, here's what that means for you as a doctor looking at homes in 2026: even if you see headlines about Fed rate cuts, your actual mortgage rate is getting pulled by bigger forces—what global investors think about inflation, how much risk they see in the economy, and whether they want to buy the bonds that back mortgages. Those forces aren't moving as fast as the Fed's announcements.
How These Forces Specifically Impact Physician Loan Rates
Physician loans exist in a fundamentally different segment of the mortgage market. Unlike conventional loans that conform to Fannie Mae and Freddie Mac guidelines, physician mortgages are portfolio products—meaning banks hold them on their own balance sheets rather than selling them to government-sponsored enterprises. This structural difference creates distinct pricing dynamics.
Portfolio lenders face balance sheet constraints that don't affect conforming loan originators. When a bank keeps a physician loan in-house, it must allocate capital against that asset and manage liquidity requirements. These considerations become particularly acute during periods of economic uncertainty or when regulatory capital requirements tighten. Banks cannot simply offload physician loans to the secondary market when they need to free up balance sheet capacity.
This portfolio structure means physician loan rates typically lag conventional mortgage movements by several weeks or months. When Treasury yields decline and conventional rates follow, physician loan rates may remain elevated as individual banks reassess their capital allocation strategies, liquidity positions, and appetite for high-leverage lending. The decision to lower physician loan rates is not automatic—it requires deliberate pricing changes by each institution based on their specific financial position.
I jokingly call this the "doctor tax" with my clients. You're getting real benefits—zero down, no PMI, flexible student loan treatment—but the trade-off is a permanent little premium baked into your rate. My job is to help you decide if that trade-off actually fits your life.
Over a 30-year mortgage term, this seemingly small spread compounds into significant additional interest expense. For physicians comparing options, this embedded cost deserves careful analysis against the benefit of immediate homeownership without a substantial down payment.
What Physician Loan Rates Look Like Going Into 2026
Current market conditions place physician loan rates in the 6.5% to 7.0% range for 30-year fixed products, reflecting both the broader mortgage environment and the physician-specific premium. This represents a modest improvement from the peak rates above 7.5% seen in late 2023 and early 2024, but rates remain substantially elevated compared to the 3.0% to 3.5% range available during the pandemic years.
Based on current forecasts as of late 2025, industry projections from Fannie Mae and Freddie Mac provide a sobering outlook for 2026. Fannie Mae projects (according to their December 2025 forecast) that conventional 30-year mortgage rates will average approximately 6.4% by the end of 2025, with the possibility of declining just below 6.0% by late 2026. Freddie Mac's recent reporting shows averages in the 6.26% to 6.58% range and aligns with expectations for only modest declines over the next 12 months.
No major forecaster anticipates a return to the sub-4.0% rates that characterized 2020-2021, barring a significant recession or deflationary shock.
Translating these conventional forecasts to physician loans requires adding the typical spread premium. If conventional rates reach 6.0% by late 2026, physician loan rates would likely settle in the 6.25% to 6.5% range under favorable conditions. However, this assumes no deterioration in bank liquidity conditions, stable inflation expectations, and continued economic stability—assumptions that carry meaningful uncertainty.
The spread between physician and conventional loans may actually widen in 2026 if banks become more conservative about balance sheet exposure or if regulatory capital requirements tighten further under Basel III implementation. During periods of financial market stress, banks typically increase premiums on portfolio products to compensate for reduced flexibility in managing these assets.
Broader industry analysis from MBS Highway and mortgage banking associations suggests rates will remain above 6.0% through the end of 2025, with most forecasts clustering between 6.3% and 6.7% for conventional products.
For you, as a doctor trying to buy a home in 2026, the takeaway is simple: plan for rates in the 6-7% range and make sure the payment still lets you sleep at night.
Structural Forces That Will Shape 2026 Rates
Three structural forces will govern the physician mortgage market in 2026, regardless of Federal Reserve policy decisions. Understanding these forces helps physicians set realistic expectations and time borrowing decisions appropriately.
Basel III Capital Constraints
Banking regulations under Basel III impose stricter capital requirements on portfolio assets, particularly high loan-to-value mortgages. Banks must hold more capital against physician loans than against conventional conforming mortgages, making these products more expensive to originate from a regulatory perspective. As Basel III standards continue phasing in through 2026, banks may become more selective about physician loan origination or may widen pricing spreads to justify the capital allocation.
These rules basically put a floor under how low banks can reasonably price physician loans. Even if Treasury yields decline dramatically, banks cannot reduce physician loan rates below the level that compensates for regulatory capital costs and balance sheet constraints.
Residential Mortgage-Backed Securities Investor Appetite
While physician loans are portfolio products, some banks do bundle physician mortgages into 'Super Prime' or 'Jumbo Prime' residential mortgage-backed securities tranches. These securitizations receive investment-grade ratings from agencies like DBRS Morningstar based on the exceptional credit performance of physician borrowers—default rates around 0.2% compared to 1.2% to 4.0% for general population mortgages.
Physician borrowers exhibit a remarkable default rate of approximately 0.2%—dramatically lower than the 1.2% to 4.0% range for general population mortgages (according to Federal Reserve and industry data). This statistical anomaly stems from three factors: income velocity (3x-5x increase from residency to attending), vocational stability (healthcare demand remains inelastic during downturns), and professional reputation risk (bankruptcy carries professional licensing scrutiny).
However, global investor appetite for these securities fluctuates based on broader economic conditions. If investors demand higher yields on mortgage-backed securities due to inflation concerns or geopolitical instability, banks must offer higher rates to physicians to make the underlying loans attractive for securitization. This connection to global capital markets means physician loan rates can be influenced by events far removed from U.S. domestic policy.
Global Macroeconomic Volatility
Big-picture global events—wars, trade fights, debt worries in other countries—shape the 2026 rate environment. These factors influence Treasury yields and investor risk appetite in ways that cascade through to physician loan pricing. Unlike conventional mortgages that benefit from implicit government backing through Fannie Mae and Freddie Mac, portfolio physician loans absorb the full impact of global risk sentiment shifts.
Physician Loan Underwriting Rules That Affect Rates
The underwriting flexibility that makes physician loans accessible to early-career doctors also creates specific rate implications. Understanding these mechanics helps physicians negotiate better terms and recognize when they might qualify for more favorable conventional financing.
Student Loan Treatment and Debt-to-Income Calculations
Conventional mortgage underwriting typically calculates student loan payments as either 1% of the outstanding balance or the fully amortized monthly payment—whichever is higher. For a physician with $300,000 in student loans, this would mean a $3,000 monthly payment assumption that makes qualifying for a mortgage nearly impossible during residency or early attending years.
Physician loan programs instead use the actual Income-Driven Repayment amount or may exclude student loans entirely from debt-to-income calculations. This fundamental deviation from standard underwriting is what enables 100% financing for borrowers carrying substantial educational debt. However, this flexibility comes at a cost—the rate premium reflects the bank's assumption of additional risk from high leverage combined with significant non-mortgage obligations.
Banks price this risk differently based on their assessment of future income trajectories. Programs that accept employment contracts for future positions—such as residents with signed attending agreements—may offer slightly better rates than programs requiring current income verification, but both will carry premiums above conventional mortgages.
Reserve Requirements and Liquidity Screening
Most physician loan programs require borrowers to maintain liquid reserves of 2 to 6 months of principal, interest, taxes, and insurance payments after closing. This requirement serves as a critical risk filter—it ensures that borrowers have demonstrated financial discipline and can weather short-term income disruptions despite taking on zero-down financing.
The reserve requirement effectively transforms physician loans from pure 'no money down' products into programs that require substantial liquidity but not necessarily equity contribution. A physician purchasing a $600,000 home might need to show $20,000 to $30,000 in accessible cash reserves post-closing, even though none of those funds are required for the down payment.
Banks that enforce stricter reserve requirements may offer marginally better rates, as the liquidity buffer reduces default risk. Physicians comparing programs should evaluate the reserve requirement alongside the interest rate to understand the true accessibility and cost of each option.
Employment Structure and Income Verification
The rise of locum tenens and 1099 contractor arrangements among physicians has created significant friction in physician loan underwriting. Most physician loan programs were designed around traditional W-2 employment with hospital systems or established practices. Lenders struggle to underwrite irregular income streams from locum work or independent contracting, as these patterns don't fit the assumptions about physician income stability that justify low default rates.
Locum physicians typically face either outright exclusion from physician loan programs or substantially higher interest rates—often 0.5% to 1.0% above standard physician loan rates. Banks may require two years of continuous 1099 income history, tax returns demonstrating income stability, and higher credit scores to compensate for perceived employment risk.
Should You Wait for Rates to Drop—or Buy Anyway?
This is probably the question I hear the most from doctors right now: "Tom, should we just wait for rates to drop?" My honest answer is: it depends less on the rate and more on your timeline, housing situation, and stress level.
When Waiting Makes Financial Sense
Waiting for lower rates is rational when several conditions align:
- You have stable, affordable housing and no urgent need to relocate
- Your local housing market shows signs of price softening or excess inventory
- You can accumulate a meaningful down payment (10% to 20%) by waiting, potentially qualifying for conventional financing with better rates
- Your career timeline is uncertain, such as during fellowship with potential geographic moves ahead
- Current rent is substantially below what homeownership would cost on a monthly basis
The critical insight is that housing prices and interest rates do not move independently. When rates decline, buyer demand typically increases, often driving home prices upward. Physicians waiting for 5.5% rates may find that home prices have appreciated 10% or more by the time those rates arrive, negating any monthly payment savings from the lower rate.
When Buying Now Is Optimal
Immediate purchase makes sense when:
- You have secured a permanent position and expect to remain in the area for at least 5 to 7 years
- Your local housing market is competitive with limited inventory, risking further price appreciation
- Your rent equals or exceeds what homeownership would cost, meaning you're building equity rather than paying a landlord
- You have substantial student loan debt that makes accumulating a conventional down payment impractical
- Your income has recently increased substantially from residency to attending status, and you can comfortably afford current rates
When I walk through the math with clients, many are surprised to see how quickly equity from price appreciation and principal paydown can outweigh the "savings" of waiting for a slightly lower rate that may or may not show up.
A physician who purchases a $500,000 home at 6.75% and experiences 3% annual appreciation builds approximately $15,000 in equity in the first year from price appreciation alone, plus $6,000 to $8,000 from principal paydown. Over five years, this compounds to roughly $100,000 in accumulated equity—far exceeding any plausible interest savings from waiting for a 6.0% rate.
Why 'Refinance Later' Is No Longer Guaranteed
The conventional wisdom of 'buy now, refinance when rates drop' faces new challenges in 2026. Refinancing requires closing costs typically ranging from 2% to 3% of the loan amount—$10,000 to $15,000 on a $500,000 mortgage. For a refinance to break even, the rate reduction must be substantial enough to recoup these costs within a reasonable timeframe, typically requiring at least a 0.75% to 1.0% rate improvement.
Given that physician loans already carry a 0.125% to 0.50% premium above conventional rates, a physician who finances at 6.75% would need conventional rates to fall below 6.0% to make refinancing economically viable. Current forecasts suggest this threshold may not be reached until late 2026 or 2027, and only under favorable economic conditions. Physicians betting on near-term refinancing opportunities may find themselves carrying higher rates longer than anticipated.
ARM vs Fixed Physician Loans Going Into 2026
Adjustable-rate mortgages represent a substantial portion of the physician loan market. In my experience and based on conversations with physician-focused lenders, ARMs can represent 30% to 40% of physician mortgage originations—several times the share in the general market (typically less than 10%). This prevalence reflects both the unique financial profile of physician borrowers and the rate incentives lenders offer on ARM products.
Why ARMs Are Common in Physician Loans
Physician ARMs typically offer initial fixed periods of 5, 7, or 10 years at rates 0.25% to 0.75% below comparable fixed-rate mortgages. For a physician who expects to relocate, upgrade, or refinance within that initial period, the ARM provides immediate payment savings without meaningful rate risk. The logic is particularly compelling for residents or fellows who anticipate moving for attending positions within 3 to 5 years.
Lenders favor physician ARMs because the shorter rate commitment period reduces interest rate risk and frees up balance sheet capacity more quickly. Banks can price these products more aggressively while still achieving acceptable returns, particularly when they anticipate higher rates in future years.
The ARM Trap of 2024-2025
Over the last couple of years, I've talked with a lot of physicians who took 2.5%–3.5% ARMs during the pandemic and are now staring at 5%+ adjustments. For some of them, that's an $800–$1,200 jump in the monthly payment. On a busy service month, that stress shows up fast.
The challenge these physicians face is acute: refinancing into current 30-year fixed rates around 6.5% to 6.75% means accepting a rate more than double their original ARM rate, while continuing with the ARM risks further adjustments if rates remain elevated or increase. This dilemma has created serious affordability concerns, particularly for those who purchased more home than they could comfortably afford at permanently higher rates.
Whether ARMs Make Sense in 2026
The ARM calculus for 2026 differs fundamentally from the pandemic environment. With current 30-year fixed rates in the 6.5% to 7.0% range and 5-year ARMs typically 0.5% to 0.75% lower, the savings from an ARM are meaningful but not dramatic—perhaps $150 to $250 monthly on a $500,000 loan.
The critical question is rate trajectory over the next 5 to 7 years. If rates decline as Fannie Mae projects, physicians with ARMs will benefit from lower adjusted rates when their initial periods expire. However, if inflation remains persistent and rates stabilize around 6.0% to 6.5%, ARM borrowers may face minimal benefit from their initial savings and will eventually adjust to rates comparable to today's fixed products.
ARMs make the most sense for physicians who:
- Have high confidence they will relocate or upgrade within 5 to 7 years
- Can comfortably afford the maximum possible adjusted payment after the initial period
- Anticipate substantial income growth that will make higher future payments manageable
- Are willing to actively monitor rates and refinance when beneficial
For physicians planning to remain in a home long-term, or those who value payment stability and budgeting certainty, the fixed-rate premium represents reasonable insurance against rate volatility. The 2024-2025 ARM adjustment wave serves as a powerful reminder that rate risk is not merely theoretical—it materializes as real payment increases that can strain even high-income households.
How Physicians Can Get the Best Rate in 2026
Securing optimal physician loan terms requires strategic shopping across multiple lenders and careful comparison of program structures. Unlike conventional mortgages where rates are relatively uniform across lenders, physician loan pricing varies significantly based on individual bank strategies, balance sheet positions, and competitive dynamics in specific markets.
Shopping Across Multiple Portfolio Lenders
Physicians should obtain rate quotes from at least three to five different lenders specializing in physician mortgages. Banks active in this space include regional institutions with strong medical community relationships, national banks with dedicated physician banking divisions, and specialized lenders focusing exclusively on medical professionals.
Rate variation among lenders can range from 0.25% to 0.50% for identical borrower profiles, translating to thousands of dollars in annual interest expense. These differences reflect each lender's current appetite for physician loans, their cost of capital, and their strategic priorities. A bank actively building its physician loan portfolio may offer aggressive pricing to attract high-value customers, while a bank reaching its portfolio allocation limits may price less competitively.
When comparing quotes, physicians must evaluate more than just the interest rate. Critical factors include:
- Reserve requirements post-closing
- Loan amount limits and jumbo loan handling
- Student loan treatment in debt-to-income calculations
- Prepayment penalties or recasting restrictions
- Closing cost structures and origination fees
Comparing Physician Loans vs Conventional at 10-20% Down
Physicians who can access funds for a 10% to 20% down payment should rigorously compare conventional financing against physician loans. With a 10% down payment, conventional loans eliminate private mortgage insurance requirements while potentially offering rates 0.25% to 0.50% below physician loan pricing.
The trade-off becomes a liquidity question. Using $80,000 for a down payment on a $400,000 purchase reduces the mortgage balance and monthly payment while securing a better rate. However, that $80,000 could alternatively be deployed for student loan paydown, investment, or maintained as emergency reserves. The optimal choice depends on the physician's broader financial situation, including student loan interest rates, investment return expectations, and comfort with liquidity buffers.
For many early-career physicians, the ability to preserve liquidity while still accessing homeownership justifies the physician loan rate premium. For established attendings with accumulated savings, conventional financing may offer superior long-term value despite requiring upfront capital deployment.
Recasting Instead of Refinancing
Mortgage recasting represents an underutilized strategy for physicians who receive substantial bonuses, inheritances, or other lump-sum payments after closing. A recast involves making a large principal payment and then requesting the lender recalculate monthly payments based on the reduced balance while maintaining the existing interest rate and term.
Unlike refinancing, which requires full underwriting, closing costs, and rate qualification, recasting typically costs $250 to $500 and can be completed quickly. For a physician who financed $500,000 at 6.75% and later pays down $100,000 in principal, a recast would reduce monthly payments from approximately $3,243 to $2,594—a savings of $649 monthly—without changing the interest rate or requiring refinancing fees.
Recasting works particularly well for physicians who used zero-down physician loans to purchase homes and subsequently accumulate cash from income growth, signing bonuses, or investment gains. Rather than refinancing into a new loan with closing costs, the recast achieves payment reduction while preserving the existing loan terms.
Not all lenders permit recasting, and some impose minimum principal payment requirements of $5,000 to $10,000. Physicians should confirm recast availability when selecting a lender, as this feature provides valuable flexibility for managing mortgage costs over time without the expense and complexity of refinancing.
Lock Timing in a Volatile Market
Rate locks protect borrowers from increases during the period between application and closing, typically 30 to 60 days. In the current volatile environment, physicians should consider extended rate locks of 45 to 60 days to ensure sufficient time for underwriting and closing without rate risk. Some lenders offer float-down provisions that allow borrowers to capture lower rates if they decline after locking, though these features often come with fees or restrictions.
The optimal lock timing depends on rate trajectory expectations and construction timelines for new builds. Physicians purchasing existing homes can typically lock rates shortly after offer acceptance. Those building custom homes may need extended locks or multiple lock extensions, each potentially carrying fees. Understanding these mechanics and negotiating lock terms during lender selection prevents last-minute rate surprises that can derail affordability calculations.
2026 Outlook: What Doctors Should Expect the Next 12 Months
The physician mortgage market in 2026 will be shaped by three converging forces: persistent inflationary pressures that keep Treasury yields elevated, regulatory capital constraints that limit bank flexibility on portfolio lending, and continued global economic uncertainty that maintains risk premiums across all mortgage products.
Physicians should anticipate physician loan rates remaining in the 6.25% to 7.0% range throughout 2026, with modest downward movement possible in the second half of the year if inflation moderates and Fed policy becomes more accommodative. Dramatic rate reductions below 6.0% remain unlikely unless economic conditions deteriorate significantly, triggering recession fears and flight-to-quality into Treasury bonds.
The spread between physician and conventional loans may widen modestly as banks become more selective about balance sheet allocation and as Basel III capital requirements continue phasing in. This widening spread makes the comparison between physician loans and conventional financing with down payments increasingly important for physicians who have accumulated savings.
For physicians in the market for homes in 2026, the strategic focus should shift from timing rate movements to optimizing the complete financial structure. This means:
- Shopping aggressively across multiple lenders to capture the best available pricing
- Carefully evaluating whether liquidity preservation through zero-down physician loans justifies the rate premium over conventional financing
- Understanding the full costs of adjustable-rate products and ensuring comfortable affordability at maximum possible adjusted rates
- Maintaining realistic expectations about refinancing opportunities and the true costs involved
- Considering home purchases as long-term equity-building opportunities rather than rate-timing exercises
The exceptional credit performance of physician borrowers—default rates around 0.2% compared to 1.2% to 4.0% for general population mortgages—ensures that physician loan products will remain available even in challenging credit environments. Banks recognize the long-term value of physician relationships and the statistical reliability of this borrower class. However, this reliability does not translate to preferential rates in absolute terms—it merely maintains access to zero-down financing that would be unavailable to other high-debt, high-leverage borrowers.
Looking beyond 2026, the structural forces keeping rates elevated may persist for several years. The pandemic-era environment of sub-4.0% rates was anomalous, driven by emergency monetary policy and deflationary economic conditions. A return to that rate environment would require similar crisis conditions—not a scenario physicians should hope for or plan around.
Instead, physicians should calibrate expectations around a 'new normal' of 6.0% to 7.0% rates and build financial plans that function effectively in this range. This means stress-testing affordability at the upper end of the range, maintaining adequate emergency reserves, and avoiding the temptation to stretch budgets based on optimistic rate forecasts that may not materialize.
The physician loan remains a powerful tool for early-career doctors to access homeownership despite high student debt and limited down payment savings. For the informed borrower who understands the true costs, compares options rigorously, and maintains appropriate financial discipline, these products facilitate wealth building through real estate ownership during the critical early attending years. For those who approach physician loans casually, assuming preferential rates or guaranteed refinancing opportunities, the current environment presents meaningful risks of over-leverage and constrained long-term financial flexibility.
If you're a physician reading this and feeling behind, you're not. The system is just confusing on purpose. My goal is to help you see the rules clearly so you can make calm, boring, smart decisions with one of the biggest loans you'll ever take out.
My advice after nearly two decades in this work: don't chase the perfect rate. Build a plan that still works at 6.5%–7.0%, protect your cash flow, and use your mortgage as a tool to support your life and career—not the other way around.
The difference between these outcomes lies not in market timing or rate predictions, but in the quality of analysis and decision-making that physicians bring to one of the largest financial commitments of their careers.